Use your antibodies-online credentials, if available.
抗Mouse (Murine) 抗体:
抗Rat (Rattus) 抗体:
Human Polyclonal EGLN2 Primary Antibody for EIA, WB - ABIN453633
Semenza: HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus. in Cell 2001
Show all 2 Pubmed References
Dog (Canine) Polyclonal EGLN2 Primary Antibody for WB - ABIN2778438
Pan, Mansfield, Bertozzi, Rudenko, Chan, Giaccia, Simon: Multiple factors affecting cellular redox status and energy metabolism modulate hypoxia-inducible factor prolyl hydroxylase activity in vivo and in vitro. in Molecular and cellular biology 2007
Show all 2 Pubmed References
Cow (Bovine) Polyclonal EGLN2 Primary Antibody for WB - ABIN2775992
Gilbert, Banek, Bauer, Gingery, Needham: Exercise training attenuates placental ischemia-induced hypertension and angiogenic imbalance in the rat. in Hypertension 2012
comparative analysis of phd1, 2, and 3 expression in Xenopus laevis
HS-induced PPARalpha (显示 PPARA 抗体)-mediated downregulation of PHD1 is a novel pathway for PHD (显示 PDC 抗体)/HIF-1alpha (显示 HIF1A 抗体) transcriptional regulation.
EglN2 might act as an FBW7 ubiquitin ligase substrate contributing to the progression of triple negative breast cancer.
Selective reduction of PHD1 protein using CRISPR/Cas9 technology reduced both lipid peroxidation and mitochondrial impairment, and attenuated glutamate (显示 GRIN1 抗体) toxicity in the cultured neurons.
Phd1 deficiency in dendritic cells significantly reduced interleukin-1beta production in response to lipopolysaccharide. Taken together, our results further support the development of selective PHD1 inhibitors for ulcerative colitis, and identify haematopoietic cells as their primary target.
PHD1 deficiency promotes hepatic steatosis and liver-specific insulin (显示 INS 抗体) resistance but does not worsen the deleterious effects of HFD on metabolic homeostasis.
deleting Phd1-3 genes in osteoblasts increased osteoclast formation in vitro and in bone.
These data identify PHD1 as a regulator of neuronal metabolism and a potential therapeutic target in ischemic stroke.
PHD1 and PHD3 (显示 EGLN3 抗体) deletions promote angiogenesis in ischemia-injured tissue by increasing HIF1-alpha (显示 HIF1A 抗体) stability.
Rosiglitazone increases PHD (显示 PDC 抗体) expression in a PPARgamma (显示 PPARG 抗体)-dependent manner and that this leads to the commitment of anti-adipogenic proteins to the ubiquitination-proteasomal pathway and to the subsequent induction of adipocyte differentiation.
PHD-1 deficient mouse appears to be the first animal model showing neuroepithelial bodies cell hyperplasia
4-bp Insertion/deletion Polymorphism within the Promoter of EGLN2 is associated with breast cancer.
Our study provided initial evidence that the insertion/deletion polymorphism rs10680577 may play a functional role in the development of CRC (显示 CALR 抗体) in the Chinese population
In advanced-stage Hodgkin's Lymphoma patients strong cytoplasmic PHD1 expression in Reed-Sternberg cells was associated with poor relapse-free survival among patients treated with involved-field radiotherapy and advanced-stage patients treated with doxorubicin, bleomycin, vinblastine and darcabazine and involved-field radiotherapy.
PHD1 is phosphorylated by CDK2 (显示 CDK2 抗体), CDK4 (显示 CDK4 抗体) and CDK6 (显示 CDK6 抗体) at Serine 130.
siRNA-mediated knockdown of PHD1 inhibited glucose-stimulated insulin (显示 INS 抗体) secretion in pancreatic Beta cells.
EglN2 associates with the NRF1 (显示 NFE2L1 抗体)-PGC1alpha complex and controls mitochondrial function in breast cancer
rs3733829 in the EGLN2 gene is significantly associated with the risk of COPD (显示 ARCN1 抗体) in Chinese populations of Hainan province.
Germ-line PHD1 and PHD2 (显示 EGLN1 抗体) mutations detected in patients with pheochromocytoma/paraganglioma-polycythemia
study conducted to investigate the association between gastric cancer (GC) susceptibility with a 4-bp insertion/deletion polymorphism (rs10680577) in the proximal promoter of EGLN2; findings showed that the heterozygote and the homozygote 4-bp del/del confer a significantly increased risk of GC
The hypoxia inducible factor (HIF) is a transcriptional complex that is involved in oxygen homeostasis. At normal oxygen levels, the alpha subunit of HIF is targeted for degration by prolyl hydroxylation. This gene encodes an enzyme responsible for this post-translational modification. Alternative splicing results in multiple transcript variants. Read-through transcription also exists between this gene and the upstream RAB4B (RAB4B, member RAS oncogene family) gene.
EGL nine homolog 2
, egl nine homolog 2
, Egl nine homolog 2
, EGL nine (C.elegans) homolog 2
, egl nine homolog 2 (C. elegans)
, egl nine homolog 2-like
, HIF-prolyl hydroxylase 1
, hypoxia-inducible factor prolyl hydroxylase 1
, immediate early response 4
, prolyl hydroxylase domain-containing protein 1
, HIF-1alpha prolyl-4-hydroxylase-1
, estrogen-induced tag 6